Placenta cancer is very rare and usually means a cancer that starts in cells that normally form the placenta after pregnancy. Early symptoms of placenta cancer can include vaginal bleeding, pelvic pain, or pregnancy hormone levels that stay high when they should fall. Placenta cancer most often affects people during or after a recent pregnancy, and it can appear weeks or months later. Not everyone will have the same experience. With prompt treatment, often chemotherapy and sometimes surgery, many people with placenta cancer do well, but delayed diagnosis can make it life-threatening.
How many people live with Placenta cancer?
For placenta cancer, usually grouped with very rare pregnancy-related cancers of the placenta, there is no single widely accepted estimate of how many people are living with it worldwide or in the United States. Major sources such as the National Cancer Institute and Orphanet describe it as very rare and usually report new cases rather than the total number of people living with it, so reliable global and U.S. prevalence numbers are not consistently available.
Overview
Placenta cancerSymptoms
Placenta cancer often causes abnormal vaginal bleeding during or after pregnancy. Some also have pelvic pain, severe nausea, or a uterus that seems larger than expected. Early symptoms of placenta cancer can sometimes be mistaken for normal pregnancy changes.
Outlook and prognosis
Placenta cancer often responds very well to treatment, especially when found early. Outlook depends on the type, how far it has spread, and blood hormone levels, but many people with placenta cancer go on to recover fully.
Causes and risk factors
Placenta cancer risk is linked to abnormal placental cell growth during pregnancy, sometimes after a molar pregnancy. Risk may be higher at very young or older maternal age, with a past molar pregnancy, and rarely with inherited susceptibility.
Genetic influences
Genetics do not seem to be a major cause of placenta cancer for most people. Most cases are not inherited, though changes in the cancer cells themselves can help doctors classify the tumor and guide treatment.
Diagnosis
Placenta cancer is usually diagnosed with a pelvic exam, blood tests for pregnancy hormone levels, ultrasound, and sometimes imaging such as CT or MRI. Diagnosis is confirmed by tissue testing after a procedure or delivery.
Treatment and drugs
Placenta cancer is usually treated with chemotherapy. Some people also need surgery to remove remaining tissue, and doctors monitor hCG blood levels closely to make sure treatment is working. Many recover fully, especially when it is found early.
Symptoms
Placenta cancer often shows up as unusual bleeding after a pregnancy, miscarriage, abortion, or delivery. You might notice small changes at first, such as spotting that seems out of place or nausea that feels stronger than expected. Because these symptoms can overlap with common postpartum or gynecologic problems, placenta cancer is sometimes missed at first. Early symptoms of placenta cancer should be checked promptly, especially if bleeding is heavy, keeps coming back, or happens with pain or shortness of breath.
The most common symptom is abnormal vaginal bleeding, often after a recent pregnancy event. It may be light spotting or much heavier bleeding, and it can come and go instead of stopping fully.
Some people with placenta cancer feel pressure, cramping, or pain low in the belly or pelvis. Day to day, it can feel like pain that does not match a normal period or postpartum recovery.
Very high pregnancy hormone levels can cause strong nausea and vomiting. This may seem out of proportion to what would usually be expected after pregnancy.
The uterus may stay enlarged or feel tender instead of shrinking back as expected after pregnancy. Some may also notice ongoing bloating or a sense of fullness in the lower abdomen.
How people usually first notice Placenta cancer?
Placenta cancer is usually first noticed after a pregnancy ends, when bleeding does not settle as expected or starts again and may be heavier than a normal period. Many people with the first signs of placenta cancer also have pregnancy hormone levels that stay unusually high, so they may notice a positive pregnancy test after a miscarriage, birth, or abortion, along with symptoms such as severe nausea, pelvic pain, or a uterus that seems larger than expected. Because these early signs can look like more common post-pregnancy problems, doctors often first suspect it when bleeding is persistent or unexplained and then confirm it with blood tests and ultrasound.
Types of Placenta cancer
Placenta cancer is not just one disease. In medical terms, cancers that grow from pregnancy-related placental tissue are usually grouped under gestational trophoblastic neoplasia, and the different types of placenta cancer can behave quite differently. Some mainly cause ongoing vaginal bleeding after a pregnancy, while others spread faster and can lead to symptoms in the lungs or other organs. Symptoms don’t always look the same for everyone.
Invasive mole
This type usually starts when a molar pregnancy grows into the wall of the uterus instead of going away completely. Many people notice persistent vaginal bleeding, pelvic discomfort, or pregnancy hormone levels that stay high after treatment. It often stays in the uterus but can sometimes spread further.
Choriocarcinoma
This is the fastest-growing form and can develop after a molar pregnancy, miscarriage, abortion, ectopic pregnancy, or full-term birth. Along with abnormal bleeding, people may have shortness of breath, chest pain, headaches, or dizziness if it has spread to the lungs or brain. Early symptoms of placenta cancer are often vague at first, so ongoing bleeding after pregnancy should be checked promptly.
Placental site tumor
This rarer type grows from the part of the placenta that attaches to the uterus. It often causes irregular bleeding months or even years after a pregnancy, and hormone levels may be only mildly raised rather than very high. Compared with choriocarcinoma, it usually grows more slowly.
Epithelioid trophoblastic tumor
This is another rare variant that can look similar to other uterine tumors at first. People often have abnormal vaginal bleeding, missed periods, or pelvic pain, and it may appear long after a prior pregnancy. Not everyone will experience every type, and this form also tends to grow more slowly than choriocarcinoma.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes, diet, exercise, or supplements can meaningfully delay the start of symptoms of placenta cancer, and this is not a condition that people can reliably prevent through everyday habits. What can help is early follow-up after a pregnancy problem such as a molar pregnancy, or prompt evaluation of unusual bleeding after pregnancy, because blood tests and checkups can sometimes find it early even though they do not stop it from developing. Keeping those follow-up visits and getting symptoms checked quickly can improve the chance of early treatment, but it cannot guarantee prevention.
What genetics can tell you about symptoms
For placenta cancer, genetics usually does not predict a clear, personal “symptom pattern” the way it can in some inherited conditions. In most cases, symptoms and how serious they become depend more on the type of tumor, how much pregnancy hormone it makes, and whether it has spread than on inherited gene changes. Rare genetic changes in the pregnancy tissue itself may affect how the disease behaves, but they are not commonly used to forecast exactly which symptoms will appear or when they will start.
Causes and risk factors
Placenta cancer most often develops after a molar pregnancy, but it can also happen after a miscarriage, ectopic pregnancy, abortion, or full-term birth. Risk is higher in people who have had gestational trophoblastic disease before and in those who become pregnant at a very young age or at an older age. Rare inherited gene changes can increase the chance of repeated molar pregnancies, but most cases are not strongly linked to family history. The main risk factors for placenta cancer are tied to pregnancy history, and no clear lifestyle or environmental cause has been proven. It’s rarely just one factor—it’s the mix that matters.
What are the most common causes or risk factors?
The biggest risk factor for placenta cancer is a past molar pregnancy, which is an abnormal pregnancy where placental tissue grows the wrong way. It can also happen after any pregnancy, including a miscarriage, abortion, ectopic pregnancy, or full-term birth, and the risk is higher in very young mothers, older mothers, and people who have had this disease before. Most cases are not inherited, but rarely an inherited gene change can make abnormal placental growth and later cancer more likely.
Environmental and biological risk factors
Placenta cancer is a rare cancer that grows from cells linked to the placenta during or after a pregnancy. Because early symptoms of placenta cancer can look like common post-pregnancy bleeding, it helps to know which situations raise risk. Doctors often group risks into internal (biological) and external (environmental). For placenta cancer, most well-established risks are biological, and no specific environmental exposure has been clearly proven to cause it.
The strongest known risk factor is a molar pregnancy, when placental tissue grows in an abnormal way instead of forming a typical pregnancy. Placenta cancer is much more likely after this kind of pregnancy than after a usual pregnancy.
A complete mole carries a higher risk than a partial mole. This is because the abnormal placental tissue is usually more extensive and more likely to keep growing.
Risk is higher at the extremes of reproductive age, especially in people younger than 20 or older than 35 to 40. Age alone does not mean placenta cancer will develop, but it is a recognized biological risk factor.
Having had a molar pregnancy or a related placental tissue tumor before raises the chance of it happening again in a future pregnancy. For many, this means doctors recommend closer follow-up after later pregnancies.
Genetic risk factors
Most placenta cancers are linked to genetic mistakes that happen in pregnancy tissue at conception, rather than a cancer gene a parent passed down. The best-known genetic causes of placenta cancer involve unusual chromosome patterns in molar pregnancies, especially complete moles. Even strong risks don’t guarantee a specific outcome, and truly inherited gene changes are rare.
Chromosome mix-up: In many cases, the placental tissue starts with a one-time chromosome error during fertilization. This usually happens by chance and often does not mean other family members are at high risk.
Complete mole: A complete molar pregnancy forms when the pregnancy tissue has genetic material only from the father, often after an empty egg is fertilized. This is the strongest known genetic pattern linked to later placenta cancer, especially a type called choriocarcinoma.
Partial mole: A partial molar pregnancy usually has an extra set of chromosomes because two sperm fertilize one egg. It can lead to persistent abnormal placental tissue, but the cancer risk is lower than after a complete mole.
Rare gene changes: Rare inherited changes in genes such as NLRP7, KHDC3L, or PADI6 can make repeated molar pregnancies more likely. Those abnormal pregnancies can increase the chance of placenta cancer developing.
Family history: A family history of recurrent molar pregnancies can be a clue to an inherited risk, although this is uncommon. If this pattern is present, genetic counseling can help clarify future pregnancy and placenta cancer risk.
Lifestyle risk factors
When people ask about lifestyle risk factors for placenta cancer, the most important point is that routine habits are not considered major proven causes. Unlike many other cancers, diet, exercise, and body weight have not been clearly shown to drive most cases. The lifestyle-related factor that matters most in practice is keeping up with recommended follow-up after a molar pregnancy or related trophoblastic disease, because delayed monitoring can allow persistent disease to grow unnoticed.
Smoking has not been established as a clear, major cause of placenta cancer. Avoiding tobacco is still wise for overall cancer health, but it is not considered a leading lifestyle driver of this condition.
Alcohol has not been shown to be a specific, well-proven risk factor for placenta cancer. Reducing heavy drinking supports general health, but current evidence does not link it strongly to this disease.
No particular diet pattern has been confirmed to cause or prevent placenta cancer. Good nutrition may support recovery during treatment, but it is not a known main trigger for the condition itself.
Low exercise levels are not recognized as a direct cause of placenta cancer. Staying active can help overall fitness and treatment tolerance, but it has not been shown to meaningfully change the chance of developing this disease.
Risk prevention
Placenta cancer is very rare, and in most cases there is no sure way to prevent it completely. This cancer most often develops from abnormal pregnancy tissue, so prevention usually focuses on lowering risk in people with known risk factors and catching problems early. Prevention is about lowering risk, not eliminating it completely. If you have had a molar pregnancy or unusual bleeding after a pregnancy, early follow-up matters because the early symptoms of placenta cancer can be easy to miss.
Regular follow-up after a molar pregnancy is one of the most important ways to lower the risk of placenta cancer being missed. Blood tests to track pregnancy hormone levels can show whether abnormal tissue is still active and needs treatment.
Early prenatal care can help spot an abnormal pregnancy, including a molar pregnancy, before it causes more serious problems. Timely treatment of abnormal pregnancy tissue may reduce the chance that placenta cancer develops later.
Unusual vaginal bleeding after a miscarriage, abortion, delivery, or molar pregnancy should be checked without delay. Fast evaluation can lead to earlier treatment if placenta cancer or related abnormal tissue is present.
After a molar pregnancy, doctors often recommend avoiding a new pregnancy until hormone levels have returned to normal for the full monitoring period. This makes follow-up clearer and helps doctors detect placenta cancer sooner if it appears.
Can you prevent Placenta cancer?
There is no proven way to fully prevent cancer that starts in placenta tissue, because it usually develops from abnormal pregnancy-related tissue and is not something everyday habits are known to stop. If you have had a molar pregnancy, which is a rare pregnancy where placenta tissue grows abnormally, or unusual bleeding after a pregnancy, miscarriage, or birth, regular follow-up care can help find problems early, but it cannot guarantee prevention.
Transmission
Placenta cancer is not contagious, so you cannot catch it from someone through kissing, sex, sharing food, blood, or everyday contact. For many living with placenta cancer, this can be reassuring: it does not spread from person to person the way an infection does.
Instead, placenta cancer usually starts when cells linked to a pregnancy begin growing abnormally, sometimes after a birth, miscarriage, or abortion. It is also not usually passed down in families like an inherited condition. Placenta cancer can spread to other parts of the body if it is not treated, but that is very different from being infectious.
When to test your genes
For placenta cancer, genetic testing is not usually used for early detection because most cases are not inherited. It may be worth discussing if you have a strong family history of cancer, an unusual age at diagnosis, or advanced or recurrent disease where tumor testing could help guide treatment or clinical trial options.
Diagnosis
Placenta cancer is usually suspected after pregnancy when bleeding, pregnancy hormone levels, or scan findings do not follow the expected pattern. For many, the first step comes when everyday activities start feeling harder because of ongoing bleeding, fatigue, or shortness of breath. Doctors usually begin with a medical history, an exam, and tests to look for signs of disease in the uterus and elsewhere. The diagnosis of placenta cancer often combines hormone testing, imaging, and a tissue sample when needed.
Your doctor will ask about recent pregnancy, miscarriage, abortion, or delivery, along with bleeding, pelvic pain, or other symptoms. Timing matters because placenta cancer often appears weeks to months after a pregnancy event.
A pelvic exam can help check for uterine enlargement, tenderness, or bleeding coming from the cervix. This gives clues, but it cannot confirm placenta cancer on its own.
Blood tests measure human chorionic gonadotropin, or hCG, the pregnancy hormone that many placenta cancers make in high amounts. Repeated hCG tests over days or weeks are often central to how placenta cancer is diagnosed because they show whether levels are rising, falling, or staying unexpectedly high.
Ultrasound is often the first imaging test used to look at the uterus and any remaining abnormal tissue after pregnancy. It can show a mass or areas with increased blood flow, although the findings are not always specific.
How is Placenta cancer diagnosed?
Placenta cancer is usually suspected when someone has unusual bleeding after a pregnancy, miscarriage, or birth, especially if blood tests show the pregnancy hormone staying high or rising when it should be falling. Doctors then use a pelvic exam, ultrasound, and sometimes imaging such as a chest X-ray or CT scan to look for abnormal tissue and see whether it has spread; in some cases, a small sample of tissue from the uterus or placenta is checked in the lab to confirm the diagnosis.
Stages of Placenta cancer
Placenta cancer does not have defined progression stages. This is because it is usually described by where the cancer is found and how far it has spread, rather than by a predictable step-by-step worsening over time. Doctors usually start with a conversation about symptoms such as abnormal bleeding after pregnancy, then use blood tests to check pregnancy hormone levels and imaging scans to look for signs of disease. If you are searching for early symptoms of placenta cancer, it is important to know that diagnosis and follow-up usually rely on a mix of symptoms, pelvic exams, blood tests, and scans over time.
Outlook and prognosis
The outlook for placenta cancer is often good when it is found early and treated promptly, especially for chemosensitive gestational trophoblastic cancers, where cure rates are very high. Many patients with disease confined to the uterus can be cured, and even some cases that have spread respond well to modern chemotherapy, with survival commonly exceeding 80% to 90% in low-risk groups. Prognosis is less favorable when the cancer is diagnosed late, has spread to the brain or liver, or belongs to rarer subtypes such as placental site trophoblastic tumor, which may respond less well to chemotherapy and sometimes require surgery. Mortality is now uncommon in specialized centers for low-risk disease, but the risk of death rises in high-risk metastatic cases or when treatment is delayed. Close follow-up with serial hCG blood testing is a major reason outcomes have improved, because it helps confirm remission and detect relapse early. Future fertility is often preserved after successful treatment, although the long-term outlook depends on the exact tumor type, stage, and response to therapy.
Long-term effects
For many people, placenta cancer can be highly treatable, especially when it is found early and hormone levels return to normal after treatment. The long-term picture is often better than with many other cancers, but some people still need years of follow-up to watch for recurrence and treatment-related problems. Long-term effects can come from both the cancer itself and from chemotherapy or, less often, surgery.
One of the main long-term concerns is that placenta cancer may come back after treatment, most often within the first year. This is why doctors usually follow pregnancy hormone levels closely over time, even when you feel well.
Many people are able to have future pregnancies after successful treatment for placenta cancer. If treatment included removal of the uterus or intensive chemotherapy, fertility may be reduced or no longer possible.
A later pregnancy is often healthy, but it usually needs closer monitoring at the start. Many living with placenta cancer ask whether pregnancy after placenta cancer is safe, and the answer is often yes once follow-up shows the disease is fully gone.
Chemotherapy can sometimes lead to lasting tiredness, nerve symptoms such as numbness or tingling, hearing changes, or effects on kidney or lung function, depending on the medicines used. The risk is higher after longer or more intensive treatment.
How is it to live with Placenta cancer?
Living with placenta cancer can feel especially overwhelming because it often appears around a time when you may have expected recovery from pregnancy, not urgent cancer care. Daily life may quickly shift toward blood tests, scans, treatment visits, and managing symptoms such as abnormal bleeding, fatigue, or shortness of breath, although many people do very well because this cancer is often highly treatable. For partners, family, and close friends, the impact can include worry, grief, and the practical strain of helping with appointments, childcare, and emotional support, so strong medical guidance and a reliable support network can make a real difference.
Treatment and drugs
Placenta cancer is usually treated based on how far it has spread, hormone blood test results, and whether someone wants future pregnancies. Many people with placenta cancer are treated with chemotherapy, because these tumors often respond very well to cancer drugs; some may need one medicine, while others need a combination. If the cancer is limited to the uterus or bleeding is heavy, surgery may be part of treatment, and in some cases doctors also use radiation for spread to places such as the brain. Doctors sometimes recommend a combination of lifestyle changes and drugs, but for placenta cancer the main focus is close follow-up with regular blood tests to make sure treatment is working and to catch any return early. Support from family or friends can make daily treatment easier, especially during repeated visits, managing side effects, and the emotional strain that can come with cancer care.
Can you cure Placenta cancer?
Yes, some cancers that start in placental tissue can often be cured, and many people do very well with treatment, especially when they are found early and treated by a specialist team. Treatment may include medicine that kills cancer cells, surgery, and careful follow-up, with the goal of curing the cancer or, if that is not possible, controlling it and easing symptoms.
Non-drug treatment
Placenta cancer usually refers to rare pregnancy-related tumors that start in placental tissue, such as some forms of gestational trophoblastic disease. Day to day, treatment often centers on removing abnormal tissue, close follow-up, and support for recovery, fertility questions, and emotional health. Beyond prescriptions, supportive therapies can also help with symptoms, strength, and coping during treatment. The best plan depends on the exact tumor type, whether it has spread, and whether future pregnancy is important to you.
Surgery is a main non-drug treatment for placenta cancer, especially when abnormal placental tissue needs to be removed or when the cancer is limited to the uterus. This may involve a suction procedure after pregnancy loss or, in some cases, a hysterectomy to remove the uterus. The choice depends on age, tumor type, bleeding, and plans for future pregnancy.
Close follow-up is essential because blood tests can show whether treatment has worked and whether the cancer has come back. Many living with placenta cancer have regular hCG blood tests for months, and sometimes imaging scans, even after symptoms improve. This careful tracking is one of the most important parts of care.
Radiation is not used for everyone, but it may help if placenta cancer has spread to places such as the brain or is causing bleeding or pain in one area. It uses focused high-energy beams to target cancer cells. Not every approach works the same way, so radiation is usually reserved for specific situations.
Fertility and pregnancy counseling can be an important part of care, especially for younger people who hope to become pregnant later. Doctors often discuss how treatment may affect the uterus, how long to wait before trying again, and why follow-up blood tests matter. For many, treatment begins not at the pharmacy, but with clear conversations about safety, timing, and future plans.
Your genes may have an impact on how drugs work for you
For people with placenta cancer, genes can sometimes affect how the body breaks down medicine, which may change how well a drug works or how strong side effects feel. Even so, for this cancer, doctors do not usually choose treatment based on inherited gene testing; care is more often guided by the exact type of disease, how far it has spread, and blood levels of the pregnancy hormone used to track it. In day-to-day terms, two people may get the same treatment but have different nausea, tiredness, or blood count changes, so the care team watches closely and adjusts treatment if needed.
Pharmacological treatments
Treatment for placenta cancer usually relies on chemotherapy, because these cancers often respond very well to drug treatment. The exact medicines depend on whether the disease is low risk or high risk, whether it has spread, and how hCG blood levels change over time. Not everyone responds to the same medication in the same way.
Methotrexate is often a first treatment for low-risk placenta cancer, especially when doctors expect a strong response from a single drug. It is usually given by injection or tablets in planned cycles, and blood tests are used to make sure hCG levels are falling.
Actinomycin-D is another common single-drug option for low-risk placenta cancer and may be used instead of methotrexate or after it if needed. It is given by vein, and it can be especially useful when early symptoms of placenta cancer are linked with rising hCG after pregnancy.
For high-risk placenta cancer, doctors often use a combination called EMA-CO, which includes etoposide, methotrexate, actinomycin-D, cyclophosphamide, and vincristine. Using several drugs together helps treat cancer that is more widespread or more likely to resist a single medicine.
If placenta cancer does not respond fully or comes back, another combination called EMA-EP may be used, adding cisplatin to etoposide, methotrexate, and actinomycin-D. If one option isn’t effective, second-line or alternative drugs may be offered.
Genetic influences
In placenta cancer, genetics usually matter more in the pregnancy tissue itself than in the family line. It’s natural to ask whether family history plays a role, but most cases are not inherited from a parent in the usual sense. Instead, placenta cancer often develops after an abnormal conception, when the fertilized egg has the wrong amount or pattern of genetic material and placental cells start growing too fast. For many living with placenta cancer, this means the problem is usually a one-time genetic error during pregnancy rather than a gene change they were born with. Rarely, people with repeated molar pregnancies may have an inherited gene change that raises the chance of these abnormal pregnancies and, in turn, the risk of cancer developing in that tissue. If doctors suspect that pattern, genetic counseling may help clarify risk and what it means for future pregnancies.
Is Placenta cancer genetic?
Genetics do not seem to be a major cause of placenta cancer for most people. Most cases are not inherited, though changes in the cancer cells themselves can help doctors classify the tumor and guide treatment.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant connected to a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with placenta cancer, the first goal is to choose treatment that clears the disease quickly while protecting overall health and, when possible, future fertility. Not every difference in response is genetic, but because placenta cancer grows from pregnancy tissue, the tumor often carries a genetic pattern linked to the pregnancy, and testing can help confirm the diagnosis. That can matter a great deal, since doctors then know they are treating placenta cancer rather than another cancer that has spread to the uterus. Unlike some other cancers, inherited genetic testing is not routinely used to decide which chemotherapy drug to start for placenta cancer. Instead, treatment is guided mainly by blood hCG levels, whether the cancer has spread, and the overall risk level when choosing between a single drug and a combination of medicines. If you are wondering how genetics affect placenta cancer treatment, their main role today is usually in confirming the disease and occasionally helping with rare cases that do not respond as expected.
Interactions with other conditions
Placenta cancer can affect more than the pregnancy itself, especially if it causes heavy bleeding, very high pregnancy hormone levels, or spread outside the uterus. Another important aspect is how it may link with other diseases: some people with placenta cancer also develop anemia from blood loss, and some may have an overactive thyroid because the tumor can raise hormone signals in the body. In day-to-day life, this can mean feeling unusually short of breath, shaky, weak, or exhausted, which may overlap with symptoms of other conditions and make them harder to sort out. If placenta cancer has spread to the lungs, liver, or brain, it can also interact with illnesses affecting those organs and change which treatments are safest. Doctors also take extra care if someone has kidney disease, liver disease, or heart problems, since these can affect chemotherapy choices and recovery. Because early symptoms of placenta cancer can look like a miscarriage or other pregnancy-related problems, careful follow-up is important to make sure the right condition is being treated.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Placenta cancer?
Symptoms that raise concern for placenta cancer, especially unusual vaginal bleeding after a pregnancy, can also happen with more common conditions such as tissue left behind in the womb after a miscarriage or birth, an ectopic pregnancy where the pregnancy grows outside the womb, or a molar pregnancy, which is an abnormal growth of pregnancy tissue. Heavy bleeding and pelvic pain may also be caused by infection in the womb or noncancerous growths such as fibroids. Because these problems can look very similar at first, doctors usually need blood tests, imaging, and sometimes a tissue sample to tell them apart.
History
Long before modern scans and blood tests, doctors noticed that some people became very unwell after a pregnancy ended, with heavy bleeding, a uterus that stayed enlarged, or symptoms that seemed out of proportion to a normal recovery. What many now think of as placenta cancer was first understood through these striking patterns rather than through a clear label. In older medical writings, cases that would now fall under placental tumors were often grouped with unusual growths of pregnancy or described only by what doctors could see during an exam or after surgery.
As medical science evolved, pathologists began to recognize that some of these growths came from the same tissue that normally helps form the placenta. That was an important shift, because it separated placenta cancer from other cancers of the uterus and helped explain why it could sometimes appear after a miscarriage, abortion, ectopic pregnancy, molar pregnancy, or full-term birth. By the late 19th and early 20th centuries, doctors had described forms such as choriocarcinoma, a fast-growing cancer linked to pregnancy tissue, although treatment at that time was still very limited.
A major turning point came in the mid-20th century, when researchers linked these cancers to a pregnancy hormone that could be measured in the blood and urine. This gave doctors a practical way to diagnose the disease, track how well treatment was working, and spot return of the cancer early. For many living with placenta cancer, this changed the experience from one of great uncertainty to one where follow-up could be much more precise.
Treatment also changed dramatically. Before effective medicines were available, placenta cancer could be life-threatening even when it was found relatively early. Chemotherapy transformed outcomes, and today many forms of gestational trophoblastic cancer are highly treatable, often even after the cancer has spread. That history still shapes care now: when doctors talk about the early symptoms of placenta cancer, such as unusual bleeding after pregnancy or persistently high pregnancy hormone levels, they are drawing on decades of progress in recognizing a disease that once was poorly understood and often much harder to treat.